Fumin Lin
-
- Regulation of Appetite and Obesity 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
-
- Metabolism, Diabetes, and Cancer 4
- Physiology top 10%
- Adipose Tissue and Metabolism 3
-
- Adipose Tissue and Metabolism 3
-
- Genomic variations and chromosomal abnormalities 3
-
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Acute Myeloid Leukemia Research 2
-
- Effects and risks of endocrine disrupting chemicals 2
- Co-authors
- Anthony R. MeansThomas J. RibarPamela NoeldnerMichael J. MuehlbauerKristin A. AndersonLee A. WittersBruce E. KempMichelle Green
- Journals
- Journal of Clinical Oncology (2 papers)Molecular Case Studies (2 papers)Cell Metabolism (1 paper)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Fumin Lin
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Endocrine and Autonomic Systems 107
- Cancer Research 185
- Molecular Biology 604
- Physiology 35
- Physiology 188
Countries citing papers authored by Fumin Lin
This map shows the geographic impact of Fumin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumin Lin more than expected).
Fields of papers citing papers by Fumin Lin
This network shows the impact of papers produced by Fumin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumin Lin. The network helps show where Fumin Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fumin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 30 | |
| 10 | 2019 | 35 | |
| 11 | 2018 | 46 | |
| 12 | 2017 | 40 | |
| 13 | 2015 | 5 | |
| 14 | 2012 | 3 | |
| 15 | 2012 | 93 | |
| 16 | 2008 | 188 | |
| 17 | 2008 | 300 | |
| 18 | 1991 | 63 | |
| 19 | 1991 | 48 | |
| 20 | 1990 | 14 |
About Fumin Lin
Fumin Lin is a scholar working on Endocrine and Autonomic Systems, Cancer Research, Genetics, Pharmacology and Molecular Biology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Genomic variations and chromosomal abnormalities (3 papers), Regulation of Appetite and Obesity (3 papers), Adipose Tissue and Metabolism (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Acute Myeloid Leukemia Research (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (107 citations), Cancer Research (185 citations), Molecular Biology (604 citations), Physiology (35 citations) and Physiology (188 citations). Fumin Lin has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Anthony R. Means, Thomas J. Ribar, Pamela Noeldner, Michael J. Muehlbauer, Kristin A. Anderson, Lee A. Witters, Bruce E. Kemp, Michelle Green, Linda S. Birnbaum and Jorge Goldstein. Their work appears in journals such as Journal of Clinical Oncology, Molecular Case Studies, Cell Metabolism, Scientific Reports and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.